Radiation Pneumonitis
-
Subject Areas on Research
- A NEIL1 single nucleotide polymorphism (rs4462560) predicts the risk of radiation-induced toxicities in esophageal cancer patients treated with definitive radiotherapy.
- A neural network model to predict lung radiation-induced pneumonitis.
- ATM polymorphisms predict severe radiation pneumonitis in patients with non-small cell lung cancer treated with definitive radiation therapy.
- Assessing the ability of the antiangiogenic and anticytokine agent thalidomide to modulate radiation-induced lung injury.
- Assessment of the protective effect of amifostine on radiation-induced pulmonary toxicity.
- Combining multiple models to generate consensus: application to radiation-induced pneumonitis prediction.
- Comparison of two Mn porphyrin-based mimics of superoxide dismutase in pulmonary radioprotection.
- Early and late administration of MnTE-2-PyP5+ in mitigation and treatment of radiation-induced lung damage.
- Early pulmonary toxicity following lung stereotactic body radiation therapy delivered in consecutive daily fractions.
- Functional polymorphisms of base excision repair genes XRCC1 and APEX1 predict risk of radiation pneumonitis in patients with non-small cell lung cancer treated with definitive radiation therapy.
- Functional promoter variant rs2868371 of HSPB1 is associated with risk of radiation pneumonitis after chemoradiation for non-small cell lung cancer.
- Genetic variants of the LIN28B gene predict severe radiation pneumonitis in patients with non-small cell lung cancer treated with definitive radiation therapy.
- Genetic variants of the nonhomologous end joining gene LIG4 and severe radiation pneumonitis in nonsmall cell lung cancer patients treated with definitive radiotherapy.
- Helical tomotherapy for bilateral breast cancer: Clinical experience.
- Incorporating single-nucleotide polymorphisms into the Lyman model to improve prediction of radiation pneumonitis.
- Investigation of the support vector machine algorithm to predict lung radiation-induced pneumonitis.
- Is a reduction in radiation lung volume and dose necessary with paclitaxel chemotherapy for node-positive breast cancer?
- Loss of heterozygosity at the mannose 6-phosphate insulin-like growth factor 2 receptor (M6P/IGF2R) locus predisposes patients to radiation-induced lung injury.
- Organs at Risk Considerations for Thoracic Stereotactic Body Radiation Therapy: What Is Safe for Lung Parenchyma?
- Phase 1 Study of Accelerated Hypofractionated Radiation Therapy With Concurrent Chemotherapy for Stage III Non-Small Cell Lung Cancer: CALGB 31102 (Alliance).
- Polymorphisms of homologous recombination genes and clinical outcomes of non-small cell lung cancer patients treated with definitive radiotherapy.
- Polymorphisms of the vascular endothelial growth factor gene and severe radiation pneumonitis in non-small cell lung cancer patients treated with definitive radiotherapy.
- Potentially Functional Variants of ATG16L2 Predict Radiation Pneumonitis and Outcomes in Patients with Non-Small Cell Lung Cancer after Definitive Radiotherapy.
- Predicting lung radiotherapy-induced pneumonitis using a model combining parametric Lyman probit with nonparametric decision trees.
- Predicting toxicity from radiation therapy--it's genetic, right?
- Prospective assessment of dosimetric/physiologic-based models for predicting radiation pneumonitis.
- Pulmonary apical cap.
- Receiver operating characteristic curves to assess predictors of radiation-induced symptomatic lung injury.
- Simple Factors Associated With Radiation-Induced Lung Toxicity After Stereotactic Body Radiation Therapy of the Thorax: A Pooled Analysis of 88 Studies.
- Single Nucleotide Polymorphisms in CBLB, a Regulator of T-Cell Response, Predict Radiation Pneumonitis and Outcomes After Definitive Radiotherapy for Non-Small-Cell Lung Cancer.
- Single nucleotide polymorphism at rs1982073:T869C of the TGFbeta 1 gene is associated with the risk of radiation pneumonitis in patients with non-small-cell lung cancer treated with definitive radiotherapy.
- Soluble TGFbeta type II receptor gene therapy ameliorates acute radiation-induced pulmonary injury in rats.
- The impact of induction chemotherapy and the associated tumor response on subsequent radiation-related changes in lung function and tumor response.
- The impact of pre-radiotherapy surgery on radiation-induced lung injury.
- The protective effect of recombinant human keratinocyte growth factor on radiation-induced pulmonary toxicity in rats.
- Updated assessment of the six-minute walk test as predictor of acute radiation-induced pneumonitis.
- Using patient data similarities to predict radiation pneumonitis via a self-organizing map.